[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100565400":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":29,"centralContacts":33,"locations":42,"responsibleParty":58,"collaborators":25,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":25,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":25,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":25,"overallStatus":44,"whyStopped":25,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"The Hospital for Sick Children","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Sterile water","PLACEBO_COMPARATOR","Participants will be given sterile water which does not contain sugar and is used as a placebo",[13],"Other: Sterile water",{"label":15,"type":16,"description":17,"interventionNames":18},"Sucrose solution","EXPERIMENTAL","Participants will be given sugar water which contains 24% sucrose. As per pharmacy at The Hospital for Sick Children, Sucrose is not classified as a drug as per Health Canada.",[19],"Other: 24% Sucrose",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"24% Sucrose","Participants will be given either sugar water (24% sucrose) randomly",[15],null,{"type":6,"name":9,"description":27,"armGroupLabels":28,"otherNames":25},"Participants will be given sterile water randomly",[9],[30],{"name":31,"affiliation":5,"role":32},"Nikolaus E. Wolter, MD","PRINCIPAL_INVESTIGATOR",[34,39],{"name":31,"role":35,"phone":36,"phoneExt":37,"email":38},"CONTACT","4168137654","204351","nikolaus.wolter@sickkids.ca",{"name":40,"role":35,"phone":25,"phoneExt":25,"email":41},"Mary-Elizabeth Vanderpost, RN","mary-elizabeth.vanderpost@sickkids.ca",[43],{"facility":5,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Toronto","Ontario","M5G 1E8","Canada","CA",{"type":51,"coordinates":52},"Point",[53,54],-79.39864,43.70643,{"lat":54,"lon":53},[57],{"name":31,"role":35,"phone":36,"phoneExt":37,"email":38},{"type":32,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Nikolaus Wolter","Staff Otolaryngologist, Department of Otolaryngology - Head & Neck Surgery","100565400","be-sweet-to-babies-during-nasolaryngoscopy-100565400",false,"NCT06641687","Be Sweet to Babies During Nasolaryngoscopy","Oral Sucrose for Pain Management During Flexible Nasolaryngoscopy","Inclusion Criteria:\n\n* Patient \\\u003C12 months of age;\n* Scheduled for an appointment with Dr. Nikolaus Wolter or Dr. Jennifer Siu, who are Staff Pediatric Otolaryngologists at the Hospital for Sick Children, or Meghan Tepsich, a complex airway Nurse Practitioner at SickKids;\n* Requiring flexible nasolaryngoscopy for diagnostic purposes;\n* Accompanied by caregivers who provided consent.\n\nExclusion Criteria:\n\n* Patient \\>12 months of age\n* Infants \\\u003C37 weeks corrected gestational age\n* Infants with decreased level of consciousness or delayed neuromuscular development with limited pain response\n* Infants who have received acute\u002Furgent \u002Femergent airway assessment such as respiratory distress or a foreign body, etc.\n* Infants who have received topical anesthesia (topical decongestant\u002Fanesthetic spray)\n* Infants with the following conditions, where oral sucrose is contraindicated or ineffective:\n\n  * Carbohydrate intolerance\n  * Decreased level of consciousness or heavy sedation\n  * Absent gag reflex\n  * Non-functional gastrointestinal tract\n  * History of aspiration, tracheoesophageal fistula\n  * Necrotizing enterocolitis\n* Infants whose parents did not consent to enrolling their child in the study, including randomization into either arm of the study due to preference for a given intervention\n* Any other circumstance in which consent for participation in the study was not obtained prior to the scope\n\nInfants will also be excluded from the study if they present with conditions in which FNL is contraindicated:\n\n* Severe respiratory distress\n* Post-palliative systemic artery to pulmonary artery shunt\n* Single ventricle congenital heart disease","ALL","1 Month","12 Months",{"count":72,"type":73},60,"ESTIMATED","INTERVENTIONAL",[76],"NA","The investigators want to know if sugar water containing 24% sucrose is helpful in reducing pain in babies during scopes.",[79],"Infant Conditions","2025-07-02",{"date":82,"type":83},"2025-07-04","ACTUAL",{"date":85,"type":83},"2024-09-23",{"date":87,"type":73},"2025-09-01",{"name":5,"class":6},1]